Array ( [1613567592] => Array ( [wordfence_hourly_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1613568726] => Array ( [wp_update_themes] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) [wp_update_plugins] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1613569173] => Array ( [wp_privacy_delete_old_export_files] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1613569474] => Array ( [wp_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613569681] => Array ( [wpm_update_stats] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1613569800] => Array ( [wordfence_start_scheduled_scan] => Array ( [67b4a16dbdd359a47a484f64bb7ae901] => Array ( [schedule] => [args] => Array ( [0] => 1613569800 ) ) ) ) [1613572153] => Array ( [wp_version_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1613575073] => Array ( [wp_session_garbage_collection] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1613578024] => Array ( [akismet_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613581011] => Array ( [yoast_tracking] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613598061] => Array ( [wpseo_permalink_structure_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) [wpseo_home_url_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613598074] => Array ( [wpseo-reindex] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613629485] => Array ( [recovery_mode_clean_expired_keys] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613632112] => Array ( [ai1wm_storage_cleanup] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613638171] => Array ( [wp_scheduled_auto_draft_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613643311] => Array ( [delete_expired_transients] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613643352] => Array ( [wpseo-reindex-links] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613644014] => Array ( [wordfence_daily_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1613829000] => Array ( [wordfence_start_scheduled_scan] => Array ( [1fe45346425a048ce3695c508490defb] => Array ( [schedule] => [args] => Array ( [0] => 1613829000 ) ) ) ) [1614088200] => Array ( [wordfence_start_scheduled_scan] => Array ( [08dff641b90d7cab1b6d1c29542d954c] => Array ( [schedule] => [args] => Array ( [0] => 1614088200 ) ) ) ) [1614147890] => Array ( [wp_site_health_scheduled_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => weekly [args] => Array ( ) [interval] => 604800 ) ) ) )
Etiquetas: Aparición del medicamento genérico y protección del medicamento innovador, Apariencia de los genéricos, Bioequivalencia, Bioequivalencia de los medicamentos genéricos, Calidad de los medicamentos genéricos, Concepto de medicamento genérico, División de Farmacología, Equivalencia, Estudios farmacocinéticos de bioequivalencia, Evaluación Clínica, Evidencias, Excipientes, genéricos, Intercambiabilidad, Marzo 2010, Medicamento genérico e intercambiabilidad, Medicamento genérico y políticas de sustitución, Médicamentos genéricos, Mitos, Regulación de los medicamentos genéricos, salud, Sanidad, Servicio de Farmacocinética, Subdirección general de Medicamentos de Uso Humano.
Etiquetas: 5 marzo 2008, 5/03/2008, Agencia española del medicamento y productos sanitarios, Circular, Cristina Avedaño Solá, Etiquetado, Excipientes, ficha técnica, Garantizar la unificación de criterios técnicos, Industria farmacéutica, informe, Madrid, Medicamentos de uso humano, Modificación, Nombre del excipiente, Nota aclratoria, Procedimientos de autorización, Profesionales sanitarios, Prospecto, salud, Sanidad, Umbral, Vía de administración.